 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              The Board of Directors of Glenmark Pharmaceuticals Ltd, at its Meeting held on May 12, 2016 allotted 8,000 equity shares to the employees of the Company on exercise of options granted to them pursuant to ESOS 2003.
The Nomination and Remuneration Committee of the Company, at its meeting held on May 12, 2016 has cancelled 27,500 stock options pursuant to ESOS 2003.
Shares of GLENMARK PHARMACEUTICALS LTD. was last trading in BSE at Rs.858.1 as compared to the previous close of Rs. 857.05. The total number of shares traded during the day was 42460 in over 2339 trades.
The stock hit an intraday high of Rs. 868.5 and intraday low of 855.45. The net turnover during the day was Rs. 36587363.